Blue Trust Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Blue Trust Inc’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$654	–	2640
2025 Q3	$654	Buy	+10	New	+$488	﹤0.01%	2384
2025 Q2	–	Sell	-259	Closed	-$7.81K	–	2536
2025 Q1	$7.81K	Hold	259	–	–	﹤0.01%	1998
2024 Q4	$9.05K	Sell	259 -27	-9%	-$1.01K	﹤0.01%	1972
2024 Q3	$13.6K	Buy	286 +179	+167%	+$8.33K	﹤0.01%	2088
2024 Q2	$4.64K	Buy	+107	New	+$4.39K	﹤0.01%	2221
2024 Q1	–	Sell	-137	Closed	-$6K	–	2457
2023 Q4	$6K	Sell	137 -712	-84%	-$34.1K	﹤0.01%	1765
2023 Q3	$35K	Hold	849	–	–	﹤0.01%	972
2023 Q2	$30K	Hold	849	–	–	﹤0.01%	890
2023 Q1	$32K	Hold	849	–	–	﹤0.01%	1199
2022 Q4	$38K	Buy	849 +174	+26%	+$7.32K	﹤0.01%	1040
2022 Q3	$25K	Hold	675	–	–	﹤0.01%	1004
2022 Q2	$25K	Buy	+675	New	+$25.5K	﹤0.01%	899

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Blue Trust Inc's IONS Position: Q4 2025 in Review

Blue Trust Inc sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 10 shares — an estimated $654 sold.

Blue Trust Inc first reported a position in IONS in Q2 2022 and held it in 12 quarters. The position peaked at $38K in Q4 2022. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

Blue Trust Inc reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Blue Trust Inc sold 10 Ionis Pharmaceuticals shares in Q4 2025, an estimated $654.
Blue Trust Inc first reported a position in Ionis Pharmaceuticals in Q2 2022 and held it in 12 quarters.
Blue Trust Inc's Ionis Pharmaceuticals position peaked at $38K in Q4 2022.
491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.